Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials

Brache, Vivian; Faúndes, Aníbal; Alvarez, Francisco; Cochón, Leila

doi:10.1016/s0010-7824(01)00289-x

Cited by 102 publications

(93 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…No unexplained adverse maternal effects have been reported during use of Implanon® in the postpartum period (11). In clinical trials, the most common non-menstrual side effects experienced when wearing an implant are reported to range from 15-25% (12)(13)(14)(15). In our study, the most frequent non-menstrual side effects experienced when wearing an implant, are; weight increases, anxiety, breast tenderness and headache (6.5 to 16%).…”

Section: Discussionmentioning

confidence: 49%

Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period

Duvan

Gözdemir

Kaygusuz

et al. 2010

J Turkish German Gynecol Assoc

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 49%

Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period

Duvan

Gözdemir

Kaygusuz

et al. 2010

J Turkish German Gynecol Assoc

View full text Add to dashboard Cite

“…Many of these symptoms are known side effects of hormonal contraception and of progestin contraceptive methods. 12,13 An integrated analysis of nonmenstrual adverse events with Implanon reported that there were no consistent differences between countries, except that far fewer adverse events were reported in Indonesia and many more in Chile than in other regions. 10 The countries involved in that study were Europe, Chile, Thailand, Singapore, and Indonesia.…”

Section: Discussionmentioning

confidence: 99%

Users’ perspectives on Implanon in Malaysia, a multicultural Asian country

Mastor¹,

Khaing²

2011

OAJC

View full text Add to dashboard Cite

Background:The primary objective of this study was to evaluate Malaysian women's perception, acceptance, and views on Implanon ® as a contraceptive method. We also aimed to identify women who favor Implanon, their vaginal bleeding patterns, nonmenstrual adverse events, reasons for discontinuation, and effect of Implanon on breastfeeding. Study design: This study followed up 140 women after insertion of Implanon at the University of Malaya Medical Centre by examination of their medical records and telephone interviews. User profile, discontinuation rate, reasons for choice of Implanon, discontinuation, menstrual and nonmenstrual side effects, and satisfaction rate were assessed. Results: The average age of users was 34.7 years, and 94.2% were para 2 and above. The ethnic distribution of the women reflected that of the general Malaysian population. The majority had at least secondary education (94.2%), with 41.2% having a higher degree. All of the users reported that they chose Implanon because it does not need compliance, and 72.1% felt that Implanon was cost-effective in the long term. Most users (70%) reported irregular menses and this was the main reason given for discontinuation. The vast majority reported an overall decrease in menstrual blood loss. Almost half (46%) suffered prolonged bleeding/spotting, and infrequent bleeding was experienced by 71 users (50.7%). Half of the women did not experience any nonmenstrual adverse events. The commonest complaint was weight gain, with the next most common complaints being hair loss, acne, headache, nausea, mood swings, and reduced libido. Most of the nursing mothers denied a reduction in breast milk. There was a high mean satisfaction score with Implanon. Conclusion: Implanon is well accepted by Malaysian women despite a high incidence of irregular bleeding which was found to be a major concern among women who discontinued the implant.

show abstract

“…La amenorrea es otra de las alteraciones que se observa con mayor frecuencia desde primer año, persistiendo hasta los dos años de uso (2,8,(11)(12)(13)(14). Se observó en el estudio que en los primeros tres meses se presenta el mismo comportamiento y persiste al final del primer año.…”

Section: Discussionunclassified

Evolución a Un Año De Los Efectos Adversos, en Una Cohorte De Pacientes Con Implante Subdérmico De Desogestrel

Patiño

et al. 2006

Rev. chil. obstet. ginecol.

View full text Add to dashboard Cite

Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials

Cited by 102 publications

References 62 publications

Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period

Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period

Users’ perspectives on Implanon in Malaysia, a multicultural Asian country

Evolución a Un Año De Los Efectos Adversos, en Una Cohorte De Pacientes Con Implante Subdérmico De Desogestrel

Contact Info

Product

Resources

About

Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials

Cited by 102 publications

References 62 publications

Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period

Etonogestrel contraceptive implant (Implanon): analysis of patient compliance and adverse effects in the breastfeeding period

Users&rsquo; perspectives on Implanon in Malaysia, a multicultural Asian country

Evolución a Un Año De Los Efectos Adversos, en Una Cohorte De Pacientes Con Implante Subdérmico De Desogestrel

Contact Info

Product

Resources

About

Users’ perspectives on Implanon in Malaysia, a multicultural Asian country